KLAS publishes its 2017 report on EMR market share finding, not surprisingly, that Epic and Cerner lead, with a fairly even split of 25.8 percent and 24.6 percent respectively, followed by Meditech with 16.6 percent.
VA Secretary David Shulkin testifies before members of the House Appropriations Committee noting that the agency will make a decision on whether to implement a commercial EHR or continue with VistA by July 2017.
A Health Affairs study concludes that the increased insurance coverage brought about by ACA did not impact access to care for those that were already insured.
A Medscape survey of 132 medical oncologists and hematologists finds that most patients do not benefit from genetic testing because results rarely point to evidence-based, clinically actionable changes to a treatment plan. Despite this, 61 percent of respondents still believe the tests are useful.